Abbott Laboratories Pakistan Ltd
Abbott Laboratories Pakistan Ltd operates in Pharmaceuticals.
Market Cap & Net Worth: Abbott Laboratories Pakistan Ltd (ABOT)
Abbott Laboratories Pakistan Ltd (KAR:ABOT) has a market capitalization of $30.58K (PKRs8.53 Million) as of March 18, 2026. Listed on the KAR stock exchange, this Pakistan-based company holds position #43113 globally and #19 in its home market, demonstrating a 8.34% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Abbott Laboratories Pakistan Ltd's stock price PKRs906.68 by its total outstanding shares 9404 (9.40K).
Abbott Laboratories Pakistan Ltd Market Cap History: 2015 to 2026
Abbott Laboratories Pakistan Ltd's market capitalization history from 2015 to 2026. Data shows growth from $15.27K to $30.58K (6.30% CAGR).
Index Memberships
Abbott Laboratories Pakistan Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Karachi 100
KSE100
|
$2.22 Million | 1.40% | #9 of 100 |
|
Karachi All Share
KSI
|
$3.34 Million | 0.93% | #15 of 448 |
Weight: Abbott Laboratories Pakistan Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Abbott Laboratories Pakistan Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Abbott Laboratories Pakistan Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Abbott Laboratories Pakistan Ltd's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
Abbott Laboratories Pakistan Ltd's market cap is 0.00 times its annual earnings
0.18x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $24.04K | $23.39 Billion | $4.02 Billion | 0.00x | 0.00x |
| 2017 | $18.32K | $26.09 Billion | $4.21 Billion | 0.00x | 0.00x |
| 2018 | $17.57K | $29.72 Billion | $2.69 Billion | 0.00x | 0.00x |
| 2019 | $12.66K | $30.16 Billion | $1.30 Billion | 0.00x | 0.00x |
| 2020 | $22.70K | $35.28 Billion | $4.54 Billion | 0.00x | 0.00x |
| 2021 | $22.92K | $42.57 Billion | $5.97 Billion | 0.00x | 0.00x |
| 2022 | $15.63K | $49.26 Billion | $3.00 Billion | 0.00x | 0.00x |
| 2023 | $15.52K | $55.48 Billion | $261.78 Million | 0.00x | 0.00x |
Competitor Companies of ABOT by Market Capitalization
Companies near Abbott Laboratories Pakistan Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Abbott Laboratories Pakistan Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3465 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6393 globally with a market cap of $1.27 Billion USD ( ₩1.86 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7113 globally with a market cap of $1.05 Billion USD ( ₩1.54 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7795 globally with a market cap of $890.75 Million USD ( ₩1.30 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3465 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩739000.00 |
| #6393 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.27 Billion | ₩89200.00 |
| #7113 | ST Pharm Co.Ltd | KQ:237690 | $1.05 Billion | ₩153400.00 |
| #7795 | Oscotec Inc | KQ:039200 | $890.75 Million | ₩54900.00 |
Abbott Laboratories Pakistan Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Abbott Laboratories Pakistan Ltd's market cap moved from $15.27K to $ 30.58K, with a yearly change of 6.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | PKRs30.58K | -13.66% |
| 2025 | PKRs35.42K | -15.16% |
| 2024 | PKRs41.75K | +168.98% |
| 2023 | PKRs15.52K | -0.67% |
| 2022 | PKRs15.63K | -31.82% |
| 2021 | PKRs22.92K | +0.99% |
| 2020 | PKRs22.70K | +79.26% |
| 2019 | PKRs12.66K | -27.92% |
| 2018 | PKRs17.57K | -4.10% |
| 2017 | PKRs18.32K | -23.80% |
| 2016 | PKRs24.04K | +57.41% |
| 2015 | PKRs15.27K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Abbott Laboratories Pakistan Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.58K USD |
| MoneyControl | $30.58K USD |
| MarketWatch | $30.58K USD |
| marketcap.company | $30.58K USD |
| Reuters | $30.58K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.